Paper Details

  1. Home
  2. Paper Details

Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

Author: KuruvillaJohn, UhmJieun

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This review discusses the current standard of care for advanced stage Hodgkin Lymphoma (HL) and explores emerging therapies, including interim FDG-PET scanning and targeted agents like brentuximab vedotin and panabinostat.
Paper Details　
Original Abstract of the Article :
ABVD continues to be the standard of care for patients with advanced stage Hodgkin Lymphoma (HL) although escalated BEACOPP has improved survival in one randomized controlled trial (RCT). More intensive regimens have higher rates of acute and late toxicities and this poses significant issues for pat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.blre.2012.04.001

データ提供：米国国立医学図書館（NLM）

Treatment of Newly Diagnosed Advanced Stage Hodgkin Lymphoma

This study delves into the complexities of treating advanced stage Hodgkin lymphoma (HL), a type of cancer that affects the lymphatic system. It's like navigating a vast desert, searching for the most effective routes to combat this challenging disease. The researchers review current treatment strategies, including the standard-of-care regimen ABVD and more intensive therapies such as escalated BEACOPP. They discuss the role of consolidation strategies like radiation and autologous stem cell transplantation (ASCT) and highlight the emerging use of interim FDG-PET scans and targeted therapies in the management of HL.

Emerging Strategies for Treating Hodgkin Lymphoma

This study showcases the evolution of HL treatment strategies. It's like discovering new pathways in a vast desert, revealing more effective and targeted approaches to combating this disease. The study highlights the importance of personalized treatment plans, integrating various therapies to maximize patient outcomes. The landscape of HL treatment is constantly evolving, and this review provides a valuable overview of the latest advancements and future directions in this field.

Hope for the Future of HL Treatment

This study offers a glimpse into the future of HL treatment. It's like finding a new oasis in the desert of cancer research, offering a more effective and personalized approach to managing this disease. The ongoing development of new therapies and diagnostic tools provides hope for individuals battling HL and their loved ones, reminding us that the journey towards a cure for cancer continues, and with each step, we come closer to a brighter future.

Dr. Camel's Conclusion

This study offers a comprehensive review of the current and emerging strategies for treating advanced stage HL. It's like navigating a vast desert, where each new discovery leads to a more effective and targeted approach to combating this disease. The study highlights the importance of personalized treatment plans, incorporating a combination of therapies to optimize patient outcomes. The quest for a cure for HL continues, and this review underscores the ongoing advancements in this field, offering hope for a brighter future for individuals battling this challenging disease.

Date :
  1. Date Completed 2012-09-20
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

22542250

DOI: Digital Object Identifier

10.1016/j.blre.2012.04.001

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.